Unknown

Dataset Information

0

Pan-cancer proteogenomic investigations identify post-transcriptional kinase targets.


ABSTRACT: Identifying genomic alterations of cancer proteins has guided the development of targeted therapies, but proteomic analyses are required to validate and reveal new treatment opportunities. Herein, we develop a new algorithm, OPPTI, to discover overexpressed kinase proteins across 10 cancer types using global mass spectrometry proteomics data of 1,071 cases. OPPTI outperforms existing methods by leveraging multiple co-expressed markers to identify targets overexpressed in a subset of tumors. OPPTI-identified overexpression of ERBB2 and EGFR proteins correlates with genomic amplifications, while CDK4/6, PDK1, and MET protein overexpression frequently occur without corresponding DNA- and RNA-level alterations. Analyzing CRISPR screen data, we confirm expression-driven dependencies of multiple currently-druggable and new target kinases whose expressions are validated by immunochemistry. Identified kinases are further associated with up-regulated phosphorylation levels of corresponding signaling pathways. Collectively, our results reveal protein-level aberrations-sometimes not observed by genomics-represent cancer vulnerabilities that may be targeted in precision oncology.

SUBMITTER: Elmas A 

PROVIDER: S-EPMC8458405 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pan-cancer proteogenomic investigations identify post-transcriptional kinase targets.

Elmas Abdulkadir A   Tharakan Serena S   Jaladanki Suraj S   Galsky Matthew D MD   Liu Tao T   Huang Kuan-Lin KL  

Communications biology 20210922 1


Identifying genomic alterations of cancer proteins has guided the development of targeted therapies, but proteomic analyses are required to validate and reveal new treatment opportunities. Herein, we develop a new algorithm, OPPTI, to discover overexpressed kinase proteins across 10 cancer types using global mass spectrometry proteomics data of 1,071 cases. OPPTI outperforms existing methods by leveraging multiple co-expressed markers to identify targets overexpressed in a subset of tumors. OPPT  ...[more]

Similar Datasets

| S-EPMC10506762 | biostudies-literature
| S-EPMC9392771 | biostudies-literature
| S-EPMC5502825 | biostudies-literature
| S-EPMC5379071 | biostudies-literature
| S-EPMC7418880 | biostudies-literature
| S-EPMC3554629 | biostudies-literature
| S-EPMC8005986 | biostudies-literature
| S-EPMC6602563 | biostudies-literature
| S-EPMC9106650 | biostudies-literature